Ontario Teachers Pension Plan Board Acquires New Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Ontario Teachers Pension Plan Board bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 4,181 shares of the company’s stock, valued at approximately $289,000.

Several other institutional investors and hedge funds also recently modified their holdings of HSIC. Invesco Ltd. lifted its stake in Henry Schein by 0.4% in the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company’s stock valued at $343,468,000 after buying an additional 17,552 shares in the last quarter. FMR LLC lifted its position in shares of Henry Schein by 6.6% in the fourth quarter. FMR LLC now owns 3,498,033 shares of the company’s stock valued at $242,064,000 after acquiring an additional 217,143 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company’s stock valued at $218,762,000 after acquiring an additional 14,876 shares during the last quarter. Lyrical Asset Management LP acquired a new position in Henry Schein in the 4th quarter valued at about $126,655,000. Finally, Clarkston Capital Partners LLC lifted its holdings in Henry Schein by 24.8% in the 4th quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company’s stock valued at $120,700,000 after purchasing an additional 346,420 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

HSIC has been the subject of a number of analyst reports. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and boosted their price objective for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Wells Fargo & Company assumed coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. UBS Group dropped their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, February 26th. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of “Moderate Buy” and an average target price of $81.10.

Check Out Our Latest Stock Report on Henry Schein

Insider Transactions at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company’s stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Stock Performance

Shares of HSIC stock opened at $64.73 on Friday. The company’s fifty day moving average price is $70.67 and its two-hundred day moving average price is $72.01. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The firm has a market capitalization of $7.93 billion, a P/E ratio of 26.64, a P/E/G ratio of 2.13 and a beta of 0.84. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSICGet Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter last year, the business earned $0.66 EPS. On average, research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Recommended Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.